Kroger (KR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Jan, 2026Executive summary
Q2 2024 delivered solid results, with identical sales excluding fuel up 1.2% year-over-year, digital sales up 11%, and delivery sales up 17%, supported by growth in loyal households and customer visits.
Adjusted FIFO operating profit was $984 million and adjusted EPS was $0.93, down 3% year-over-year; GAAP operating profit was $815 million and net earnings were $466 million.
The company advanced integration work and financing for the pending Albertsons merger, including a $10.5 billion senior notes offering and amended divestiture agreements.
Recognized for sustainability, workplace inclusion, and community impact, with multiple awards and scholarships granted.
The business model remains resilient amid economic pressures, with customers trading down and focusing on essentials.
Financial highlights
Q2 2024 sales were $33.9 billion, flat year-over-year; sales excluding fuel rose 1.3%.
Net income attributable to Kroger was $466 million, or $0.64 per diluted share, compared to a net loss of $180 million in Q2 2023, which included a $1.4 billion opioid settlement charge.
Gross margin was 22.6% of sales; FIFO gross margin rate excluding fuel improved by 42 basis points year-over-year.
Net total debt to adjusted EBITDA ratio improved to 1.24, well below the target range of 2.3–2.5.
Adjusted free cash flow guidance for FY24 is $2.5–$2.7 billion, with capital expenditures expected at $3.6–$3.8 billion.
Outlook and guidance
Full-year identical sales without fuel guidance raised to 0.75%–1.75%.
FY24 adjusted FIFO operating profit expected at $4.6–$4.8 billion and adjusted EPS at $4.30–$4.50.
CapEx guidance increased to $3.6–$3.8 billion, reflecting accelerated store projects.
Adjusted free cash flow guidance unchanged despite higher CapEx.
Tax rate expected at 23% for FY24.
Latest events from Kroger
- Strong sales, margin gains, and eCommerce growth, with 2026 guidance signaling continued momentum.KR
Q4 20265 Mar 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 20253 Feb 2026 - Q1 sales and digital growth offset profit declines as guidance and merger focus remain.KR
Q1 20253 Feb 2026 - Q3 digital and pharmacy gains offset lower fuel sales; Albertsons merger terminated, $7.5B buyback set.KR
Q3 202511 Jan 2026 - Strong 2024 sales and digital growth set the stage for further gains and capital returns in 2025.KR
Q4 20256 Jan 2026 - Q2 2025 delivered strong sales, margin growth, and raised guidance, led by eCommerce and pharmacy.KR
Q2 202615 Dec 2025 - Adjusted EPS rose 7% to $1.05, but a $2.6B impairment drove a net loss.KR
Q3 202612 Dec 2025 - Board recommends director elections, pay approval, auditor ratification, and opposes all shareholder proposals.KR
Proxy Filing1 Dec 2025 - Virtual meeting to vote on directors, pay, auditor, and key proposals; board supports all nominees.KR
Proxy Filing1 Dec 2025